|
⚲
|
| Keyboard |
| Raphael Wisniewski | |
|---|---|
| Firm | |
| Address | 120 Forbes Blvd Suite 125 Mansfield, MA 02048 |
| Source |
| Associated Funds | Form D | Role | 2011 - 2026 | Raised | AUM |
|---|---|---|---|---|---|
| Bioventrix Inc | 021-477788 | Director | 12.7 M of 15.7 M |
||
| Axonics Modulation Technologies Inc | 021-286592 | Director | 55.1 M of 55.1 M |
||
| Chase Pharmaceuticals Corp | 021-260084 | Director | 12.0 M of 12.0 M |
||
| Chase Pharmaceuticals Corp | 021-257591 | Director | of 0.1 M |
||
| Chase Pharmaceuticals Corp | 021-257589 | Director | of 0.6 M |
||
| Axonics Modulation Technologies Inc | 021-253511 | Director | 38.5 M of 38.5 M |
||
| Chase Pharmaceuticals Corp | 021-246193 | Director | 3.5 M of 3.5 M |
||
| Axonics Modulation Technologies Inc | 021-238830 | Director | 17.3 M of 17.3 M |
||
| Chase Pharmaceuticals Corp | 021-218283 | Director | 6.1 M of 8.6 M |
||
| Axonics Modulation Technologies Inc | 021-214560 | Director | 13.5 M of 35.0 M |
||
| Regado Biosciences Inc | 021-212433 | Director | 20.0 M of 20.0 M |
||
| Related People Network |
|---|
| Network #314 at Bioventrix Inc — files alongside 11 co-filers |